60 related articles for article (PubMed ID: 8549761)
1. Pb2+ reduces the current from NMDA receptors expressed in Xenopus oocytes.
Yamada Y; Ujihara H; Sada H; Ban T
FEBS Lett; 1995 Dec; 377(3):390-2. PubMed ID: 8549761
[TBL] [Abstract][Full Text] [Related]
2. The sensitivity of N-methyl-D-aspartate receptors to lead inhibition is dependent on the receptor subunit composition.
Omelchenko IA; Nelson CS; Marino JL; Allen CN
J Pharmacol Exp Ther; 1996 Jul; 278(1):15-20. PubMed ID: 8764330
[TBL] [Abstract][Full Text] [Related]
3. Differential ethanol sensitivity of recombinant N-methyl-D-aspartate receptor subunits.
Masood K; Wu C; Brauneis U; Weight FF
Mol Pharmacol; 1994 Feb; 45(2):324-9. PubMed ID: 8114679
[TBL] [Abstract][Full Text] [Related]
4. Lead inhibition of N-methyl-D-aspartate receptors containing NR2A, NR2C and NR2D subunits.
Omelchenko IA; Nelson CS; Allen CN
J Pharmacol Exp Ther; 1997 Sep; 282(3):1458-64. PubMed ID: 9316859
[TBL] [Abstract][Full Text] [Related]
5. Subunit-specific redox modulation of NMDA receptors expressed in Xenopus oocytes.
Omerovic A; Chen SJ; Leonard JP; Kelso SR
J Recept Signal Transduct Res; 1995 Jul; 15(6):811-27. PubMed ID: 7584513
[TBL] [Abstract][Full Text] [Related]
6. Differential sensitivity of recombinant N-methyl-D-aspartate receptor subunits to inhibition by dynorphin.
Brauneis U; Oz M; Peoples RW; Weight FF; Zhang L
J Pharmacol Exp Ther; 1996 Dec; 279(3):1063-8. PubMed ID: 8968325
[TBL] [Abstract][Full Text] [Related]
7. Effect of agmatine on heteromeric N-methyl-D-aspartate receptor channels.
Askalany AR; Yamakura T; Petrenko AB; Kohno T; Sakimura K; Baba H
Neurosci Res; 2005 Aug; 52(4):387-92. PubMed ID: 15982768
[TBL] [Abstract][Full Text] [Related]
8. Adenosine triphosphate acts as both a competitive antagonist and a positive allosteric modulator at recombinant N-methyl-D-aspartate receptors.
Kloda A; Clements JD; Lewis RJ; Adams DJ
Mol Pharmacol; 2004 Jun; 65(6):1386-96. PubMed ID: 15155832
[TBL] [Abstract][Full Text] [Related]
9. Equilibrium constants for (R)-[(S)-1-(4-bromo-phenyl)-ethylamino]-(2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-methyl]-phosphonic acid (NVP-AAM077) acting at recombinant NR1/NR2A and NR1/NR2B N-methyl-D-aspartate receptors: Implications for studies of synaptic transmission.
Frizelle PA; Chen PE; Wyllie DJ
Mol Pharmacol; 2006 Sep; 70(3):1022-32. PubMed ID: 16778008
[TBL] [Abstract][Full Text] [Related]
10. Molecular diversity of the NMDA receptor channel.
Kutsuwada T; Kashiwabuchi N; Mori H; Sakimura K; Kushiya E; Araki K; Meguro H; Masaki H; Kumanishi T; Arakawa M
Nature; 1992 Jul; 358(6381):36-41. PubMed ID: 1377365
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of the carboxyl-terminal domain of the zeta 1 subunit is not responsible for potentiation by TPA of the NMDA receptor channel.
Yamakura T; Mori H; Shimoji K; Mishina M
Biochem Biophys Res Commun; 1993 Nov; 196(3):1537-44. PubMed ID: 7504480
[TBL] [Abstract][Full Text] [Related]
12. The interaction of general anaesthetics with recombinant GABAA and glycine receptors expressed in Xenopus laevis oocytes: a comparative study.
Pistis M; Belelli D; Peters JA; Lambert JJ
Br J Pharmacol; 1997 Dec; 122(8):1707-19. PubMed ID: 9422818
[TBL] [Abstract][Full Text] [Related]
13. Glycine and calcium-dependent effects of lead on N-methyl-D-aspartate receptor function in rat hippocampal neurons.
Marchioro M; Swanson KL; Aracava Y; Albuquerque EX
J Pharmacol Exp Ther; 1996 Oct; 279(1):143-53. PubMed ID: 8858987
[TBL] [Abstract][Full Text] [Related]
14. Structural features of the glutamate binding site in recombinant NR1/NR2A N-methyl-D-aspartate receptors determined by site-directed mutagenesis and molecular modeling.
Chen PE; Geballe MT; Stansfeld PJ; Johnston AR; Yuan H; Jacob AL; Snyder JP; Traynelis SF; Wyllie DJ
Mol Pharmacol; 2005 May; 67(5):1470-84. PubMed ID: 15703381
[TBL] [Abstract][Full Text] [Related]
15. Cloning and functional characterization of human heteromeric N-methyl-D-aspartate receptors.
Hess SD; Daggett LP; Crona J; Deal C; Lu CC; Urrutia A; Chavez-Noriega L; Ellis SB; Johnson EC; Veliçelebi G
J Pharmacol Exp Ther; 1996 Aug; 278(2):808-16. PubMed ID: 8768735
[TBL] [Abstract][Full Text] [Related]
16. Characterization of haloperidol and trifluperidol as subtype-selective N-methyl-D-aspartate (NMDA) receptor antagonists using [3H]TCP and [3H]ifenprodil binding in rat brain membranes.
Coughenour LL; Cordon JJ
J Pharmacol Exp Ther; 1997 Feb; 280(2):584-92. PubMed ID: 9023267
[TBL] [Abstract][Full Text] [Related]
17. Effects of propofol on various AMPA-, kainate- and NMDA-selective glutamate receptor channels expressed in Xenopus oocytes.
Yamakura T; Sakimura K; Shimoji K; Mishina M
Neurosci Lett; 1995 Mar; 188(3):187-90. PubMed ID: 7609905
[TBL] [Abstract][Full Text] [Related]
18. Lead inhibition of NMDA channels in native and recombinant receptors.
Gavazzo P; Gazzoli A; Mazzolini M; Marchetti C
Neuroreport; 2001 Oct; 12(14):3121-5. PubMed ID: 11568649
[TBL] [Abstract][Full Text] [Related]
19. Blockade and enhancement of glutamate receptor responses in Xenopus oocytes by methylated arsenicals.
Krüger K; Gruner J; Madeja M; Hartmann LM; Hirner AV; Binding N; Musshoff U
Arch Toxicol; 2006 Aug; 80(8):492-501. PubMed ID: 16474957
[TBL] [Abstract][Full Text] [Related]
20. Glutamate transporter type 3 attenuates the activation of N-methyl-D-aspartate receptors co-expressed in Xenopus oocytes.
Zuo Z; Fang H
J Exp Biol; 2005 Jun; 208(Pt 11):2063-70. PubMed ID: 15914650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
